Back to Search
Start Over
Differences in suppression of regrowth and resistance despite similar initial bacterial killing for meropenem and piperacillin/tazobactam against Pseudomonas aeruginosa and Escherichia coli.
- Source :
-
Diagnostic microbiology and infectious disease [Diagn Microbiol Infect Dis] 2018 May; Vol. 91 (1), pp. 69-76. Date of Electronic Publication: 2018 Jan 03. - Publication Year :
- 2018
-
Abstract
- We described bacterial killing and resistance emergence at various fixed concentrations of meropenem and piperacillin/tazobactam against Pseudomonas aeruginosa and Escherichia coli. Time-kill studies were conducted utilizing nine isolates and a large range of concentrations. Within each strain and antibiotic, initial killing was similar, with concentrations ≥2×MIC. At many (strain-specific) concentrations causing substantial initial killing, regrowth occurred at 24-48h. For remaining concentrations, growth typically remained suppressed (<5-log <subscript>10</subscript> cfu/mL). The concentrations of meropenem required to suppress regrowth ranged from 2-8×MIC for P. aeruginosa and 2-64×MIC for E. coli. For piperacillin/tazobactam, the equivalent concentrations ranged from 8-16×MIC for P. aeruginosa and 4-16×MIC for E. coli. The number of less-susceptible bacteria increased with rising concentrations before decreasing at even higher concentrations. Suppression of regrowth and resistance was substantially improved with higher concentrations (typically ≥8×MIC), suggesting a benefit of higher β-lactam concentrations beyond those required for maximum initial killing.<br /> (Copyright © 2018. Published by Elsevier Inc.)
- Subjects :
- Escherichia coli growth & development
Escherichia coli isolation & purification
Humans
Meropenem
Microbial Sensitivity Tests
Penicillanic Acid analogs & derivatives
Penicillanic Acid pharmacology
Piperacillin pharmacology
Piperacillin, Tazobactam Drug Combination
Pseudomonas aeruginosa growth & development
Pseudomonas aeruginosa isolation & purification
Thienamycins pharmacology
beta-Lactam Resistance
Anti-Bacterial Agents pharmacology
Escherichia coli drug effects
Escherichia coli Infections microbiology
Pseudomonas Infections microbiology
Pseudomonas aeruginosa drug effects
beta-Lactamase Inhibitors pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 1879-0070
- Volume :
- 91
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Diagnostic microbiology and infectious disease
- Publication Type :
- Academic Journal
- Accession number :
- 29395712
- Full Text :
- https://doi.org/10.1016/j.diagmicrobio.2017.12.019